Halda Therapeutics

News

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy Halda Therapeutics and its RIPTAC anticancer platform.

News

International cancer experts have called for big changes to bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.